All Posts

GLP-1 receptor agonists like Ozempic, Wegovy, Rybelsus, and Mounjaro have become popular for supporting weight loss... but what are the after effects on our skin?

Weight loss treatments have evolved rapidly in recent years, offering new hope for people seeking effective and convenient options. Eli Lilly’s newly FDA-approved oral tablet, Foundayo (orforglipron), joins this growing field as an alternative to injectable medications like Mounjaro and Wegovy, and in direct competition with Novo Nordisk's current offering of oral semaglutide (Ozempic/Wegovy), which is available in the UK as Rybelsus. Foundayo oral tablet close-up What is Fou

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Results of a late-stage trial show that Type 2 diabetes patients using Eli Lilly’s highly anticipated next-generation weight-loss drug Retatrutide experienced a significant reduction in blood-sugar levels and weight loss...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with Semaglutide, the well-known active ingredient within Ozempic, Rybelsus and Wegovy.

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)

New research shows that weight-loss drugs could treat addiction to alcohol, cigarettes, gambling and drugs. Experts believe the way the GLP-1 and GIP blockbuster weight loss medications work on the brain’s reward pathway can help reduce cravings for many different substances, not just food. Mounjaro, a GLP-1 Receptor Agonist that helps aid weight loss Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Wegovy, and glucose-dependent insulinotropic polypeptide (GIP) li